What is Eddingpharm?
Headquartered in Kowloon, Hong Kong, Eddingpharm operates as a Chinese specialty pharmaceutical firm. The company's product portfolio is focused on critical therapeutic areas, including anti-infective drugs, treatments for respiratory system diseases, and anti-cancer medications. This strategic focus positions Eddingpharm to address significant healthcare needs within its market.
How much funding has Eddingpharm raised?
Eddingpharm has raised a total of $45.9M across 2 funding rounds:
Series A
$21.9M
Series B
$24M
Series A (2009): $21.9M with participation from Merrill Lynch
Series B (2010): $24M led by Steamboat Ventures, Domain Associates, and OrbiMed
Key Investors in Eddingpharm
Steamboat Ventures
Steamboat Ventures, founded in 2000, focuses on helping young companies become market leaders. They invest in early to growth stage companies within the technology, media, and consumer sectors. The firm is dedicated to creating lasting value in each of its investments.
Domain Associates
DomainVC is an investment advisory firm established in 1985, specializing in biotech investments. It manages nine subsequent biotech venture capital funds and has a total of $2.8 billion in assets. The firm has provided VC funding to 194 biopharmaceutical, device, and diagnostic companies.
Merrill Lynch
Merrill Lynch, a global financial services firm, has a history of providing significant investment backing to companies across various sectors. Their involvement suggests a strategic financial partnership aimed at supporting corporate growth and market development.
What's next for Eddingpharm?
The substantial enterprise-level funding and recent strategic investment indicate a phase of accelerated growth and market expansion for Eddingpharm. This capital infusion is likely to fuel further research and development, enhance manufacturing capabilities, and broaden the company's commercial reach. The company's trajectory suggests a strong potential for future advancements in specialty pharmaceuticals.
See full Eddingpharm company page
